Iguratimod
A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-κB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBα degradation.
Product Specifications
CAS Number
123663-49-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
374.3679
Molecular Formula
C17H14N2O6S
Notes
Research use only, not for human use.
Receptor
COX-2|MIF
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1042370-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Putative uncharacterized protein yliL (yliL)
Ask
View Details MBS1042370-02 0.1 mg (E-Coli)
Recombinant Escherichia coli Putative uncharacterized protein yliL (yliL)
Ask
View Details 
MBS1042370-03 0.02 mg (Yeast)
Recombinant Escherichia coli Putative uncharacterized protein yliL (yliL)
Ask
View Details MBS1042370-04 0.1 mg (Yeast)
Recombinant Escherichia coli Putative uncharacterized protein yliL (yliL)
Ask
View Details 
MBS1042370-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli Putative uncharacterized protein yliL (yliL)
Ask
View Details MBS1042370-06 1 mg (E-Coli)
Recombinant Escherichia coli Putative uncharacterized protein yliL (yliL)
Ask
View Details